Cargando…
Schistosomiasis vaccine development: update on human clinical trials
Schistosomiasis causes significant levels of morbidity and mortality in many geographical regions of the world. The disease is caused by infections with parasitic blood flukes known as schistosomes. The control of schistosomiasis over the last several decades has been centered on the mass drug admin...
Autor principal: | Molehin, Adebayo J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977295/ https://www.ncbi.nlm.nih.gov/pubmed/31969170 http://dx.doi.org/10.1186/s12929-020-0621-y |
Ejemplares similares
-
Current Understanding of Immunity Against Schistosomiasis: Impact on Vaccine and Drug Development
por: Molehin, Adebayo J
Publicado: (2020) -
Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects
por: Molehin, Adebayo J., et al.
Publicado: (2022) -
Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment
por: Melkus, Michael W., et al.
Publicado: (2020) -
Clinical Spectrum of Schistosomiasis: An Update
por: Carbonell, Cristina, et al.
Publicado: (2021) -
Process Development of Sj-p80: A Low-Cost Transmission-Blocking Veterinary Vaccine for Asiatic Schistosomiasis
por: Molehin, Adebayo J., et al.
Publicado: (2021)